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ABSTRACT  
The survey was carried out to determine the prevalence of 
Hepatitis B virus markers among blood donors from National 
Blood Transfusion Service (NBTS) centre in Kaduna, Nigeria. 
Five milliliters of blood was collected through the vein into the 
EDTA container and screened for Hepatitis B virus (HBV) using 
diagnostic kit for HBV infection marker in whole blood. The socio-
demographic factors associated with HBV infection were 
determined using structured questionnaires. The prevalence of 
HBV markers among blood donors was compared using Pearson 
correlation matrix. The total prevalence rates of the five (5) HBV 
markers were: HBsAg 12(7.3 %), HBsAb 5(3.0 %), HBeAb 12(7.3 
%), HBcAb 18(10.9 %) while all blood samples were negative for 
HBeAg. Statistically, there were significant differences between 
the rate of prevalence for HBsAb and age, likewise HBcAb and 
occupation at (p<0.05). A high significant correlation was found 
between HBsAg and HBcAb at r=0.725 and p=0.0001, between 
HBsAg and HBeAb at r=0.820 and p=0.0001 as well. Additionally, 
there was a high significant correlation between HBcAb and 
HBsAb at r=0.278 and p=0.0001, between HBcAb and HBeAb at 
r=0.725 and p=0.0001. However, HBsAg and HBcAb have no 
significant correlation with any other HBV markers (P>0.01). 
Some of the samples that were HBsAg negative have been found 
to be positive for other HBV markers specifically HBcAb (IgG and 
IgM). Therefore, based on this study screening for HBsAg alone 
might not be sufficient for diagnosis of HBV infection.  
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INTRODUCTION 
One of the most essential and crucial section of the medical 
services is blood transfusion. The prime concern of the blood 
transfusion service is to ensure the preservation, intelligibility 
competence, and efficacy of blood supplies at all stages (Islam, 
2009). The freight of hepatitis B infection in major part of the 
developing countries particularly in rural areas is hefty; this freight 
is constituted by the lofty cost of management, treatment and 
prevention (Rosa et al., 2015). Hepatitis B virus (HBV) is a double 
stranded circular DNA virus, belongs to the family Hepadnaviridae 
(Prescott et al., 2008).  It possesses a complicated structure and 
is amongst the most contagious diseases worldwide (Blattacharya 
et al., 2007), emerging in fatal chronic liver diseases. According to 
World Health Organization (WHO), the present universal burden 
of hepatitis B infection have been predicted about two billion, from 
whom three hundred and sixty million have chronic infection by 
end of 2016, whereas six hundred and twenty thousand dies 
yearly (Wiktor and Hutin, 2016). Recently, WHO estimated that 
two hundred and fifty-seven million individuals are carriers of 
hepatitis B infection that is, HBsAg+ (WHO, 2019). Similarly, HBV 
is responsible for higher number of deaths as compared to 
malaria, tuberculosis and HIV yearly (Wiktor and Hutin, 2016). 
HBV infection is among the most frequent cause of liver disease 
and is a serious health challenge in Nigeria (Musa et al., 2015). 
Seventy-five (75) percent of the total population is discovered to 
be infected with hepatitis B virus at some point in their life, with 
approximately 12 % prevalence of chronic carriers (Alao et al., 
2009; Oladele et al., 2013). The incubation period of hepatitis B 
virus is 30-180 days (Chang, 2007). HBV continues to be the 
leading threat for secure blood usage (Ikerionwu, 2018). 
Individuals that are not immunized can easily pass on the 
hepatitis B virus, through contact with contaminated blood or body 
fluids like semen, vaginal discharge, saliva, menstrual fluid and 
blood (Rubin and Strayer, 2015). Hence they are acquired 
through contaminated blood transfusion, intercourse specifically 
sex without condoms, exchanging sharp infected items like 
syringes, scalpel, as well as personal contact in congested 
environment (Rubin and Strayer, 2015). It can also be passed on 
from an infectious mother to the fetus via the placental barrier. 
Many people at the time of initial diagnosis are asymptomatic, but 
few result in a rapid progression of the disease along with dark 
urine, throwing up, fatigue, stomach pain and yellowish skin. 
These symptoms will usually continue for a few days, and the 
primary disease rarely progresses to death (Rubin and Strayer, 
2015). HBcAb IgG is helpful for detecting chronic HBV infection, 
while HBcAb IgM is helpful in detecting recent HBV infection. 
Hepatitis B surface antigen has the ability to produce viral 
particles which have a complicated surface antigen and is 
extensively disseminated in the bloodstream of infected 
individuals. There is a period when hepatitis B surface antigen 
can’t be detected within the bloodstream, even though HBV 
infection still exists in the bloodstream. During the window phase, 
recognized antibody produced in response to hepatitis B core 
antigen functions like an effective serological marker for HBV 
infection (Bharath and Krishnan, 2016). Lack of Hepatitis B 
surface antigen in bloodstream of possibly active people might not 
be adequate to assure lack of disseminating HBV, so blood 
consisting of anti-HBc either with or without observable 
appearance of HBsAg could be infectious (Japhet, 2011; 
Jeremiah, 2011). HBV residual volume is higher through 
transfusion, this is ascribed to the period between initial HBV 
infection and observation of HBsAg, which result into a long 
window period at the same time in which the virus is transmitted 
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may either be acute or chronic hepatitis (Gerlich, 2013). This 
study is concerned primarily with the sero-prevalence of hepatitis 
B virus among blood donors from National Blood Transfusion 
Service centre in Kaduna, Nigeria. 
 
MATERIALS AND METHODS 
Subjects 
The study included apparently healthy blood donors both males 
and females who came to donate blood in national blood 
transfusion service (NBTS) centre in Kaduna, Nigeria between 
July to September 2019. 
The sample size was determined using Cochran’s formula 
 
𝑛 =
𝑡2 ×  𝑝(1 − 𝑝)
𝑚2
 
                                                                                                   
(Cochran, 1977). 
Where n is the required sample size, t represented confidence 
level at 95% (standard value of 1.96), p represented 12% (Edia-
Asuke et al., 2016), average prevalence of HBsAg+ in Nigeria 
from previous studies, m equaled 5% (standard value of 0.05) 
margin of error. A total of 165 donor samples were taken. 
Therefore, 165 blood samples were collected from prospective 
blood donors. All the Institutional and ministry of health ethical 
clearance for this study was given by the department of 
Microbiology, Kaduna State University of Science and Ministry of 
Health Kaduna. All the participants gave their written informed 
consents before blood samples were collected from them. 
 
Sample Collection 
Five milliliters of blood were collected through the vein into the 
EDTA container. The cassette was kept to the right side matching 
to HBsAg, HBsAb, HBeAg, HBeAb HBcAb. With a small pipette 
the whole blood sample was taken and added into the five (5) 
wells of the cassette by dropping (25µl per well or one drop), 
Then one drop of the buffer was added into the five (5) sample 
well as well. The interpretation of test results was performed 
according to manufacturer’s description.  The plasma for positive 
blood samples was separated through centrifugation at 5000rpm 
for 15 minutes 
 
Detection of Hepatitis B Markers 
For hepatitis B virus, a diagnostic kit for HBV infection marker in 
whole blood manufactured by micro point technologies Inc U.S.A 
was used in a stepwise order for the detection of HBsAg, HBsAb, 
HBeAg, HBeAb and HBcAb respectively in the blood. This 
method which is immunochromatographic and qualitative in 
nature, detects the presence of five markers of hepatitis B virus in 
human blood and can be read in-vitro having more than 99.9 % 
sensitivity and 99.75 % specificity.  
 
Socio-demographic Profile 
A structured questionnaire was used to obtain information on 
socio-demographic factors (gender, age and occupation). 
 
Statistical Analysis 
The data was subjected to statistical analysis and chi square test 
was carried out using SPSS computer software version 23.0 for 
windows to determine any significant relationship between age, 




The Prevalence of Hepatitis B Markers among Blood Donors 
One hundred and sixty-five blood donors took part in this study at 
the NBTS centre Kaduna.  Of the 165 blood samples tested, 
HBsAg was detected in 12(7.3 %), HBsAb 5(3.0 %), HBeAb 
12(7.3 %), and HBcAb 18(10.9 %). All blood samples were 
negative for HBeAg. The total prevalence of positive and negative 
markers detected were 7.13 % and 94.3 % respectively (Table 1). 
 




Twenty-eight female blood donor’s participated in this study, of 
which 3(1.8 %), 1(0.6 %), 2(1.2 %), 3(1.8 %) were positive for 
HBsAg, HBsAb, HBeAb and HBcAb respectively. Of the one 
hundred and thirty-seven males who participated in this study, 
9(5.5 %), 4(2.4 %), 10(6.1 %), 15(9.1 %) were positive for HBsAg, 
HBsAb, HBeAb and HBcAb respectively. Both females and male 
donors have been negative for HBeAg. This result showed no 
significant difference (p<0.05) among the distribution of hepatitis 
B markers between the blood donors based on gender (Table 2). 
 
Socio-demographic Profile  
The prevalence of Hepatitis B Markers among blood donors in 
relation to gender, age and occupation are presented as follows; 
                                         
Table 2: The Prevalence of Hepatitis B Markers among Blood 
Donors by Gender 
 
 
In terms of age, hepatitis B markers were significantly higher in 
age group 18-27 years as related with other age group. Also, 
those within 18-27 years have high positivity of 4(2.4%),5(3.0 %), 
5(3.0 %) for HBsAg, HBeAb and HBcAb respectively. Additionally, 
those with age group 58+ had lower positivity for HBV markers as 
compared with other age groups. All age groups have shown no 
significant differences (p<0.05) in relation to HBsAg, HBeAb and 
HBcAb whereas all age groups showed highly significant 
association with HBsAb (χ2= 13.373, df= 4, p= 0.010). 
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In regard to occupation, blood donors who are self-employed 
have significantly higher HBV markers as compared with other 
line of works. Students and blood donors with other occupations 
have similar positivity of 3(1.8 %) for HBsAg while civil servants 
have high positivity of 2(1.2 %) for HBsAb. Students have high 
positivity of 4(2.4 %) for HBeAb whereas self-employed have high 
positivity of 5(3.0 %) for HBcAb. All line of works has shown no 
significant difference (p<0.05) in relation to HBsAg, HBsAb and 
HBeAb. Although all line of works showed highly significant 
association with HBcAb (χ2=10.860, df= 4, p=0.028). On the other 
hand, all line of works were negative for HBeAg (Table 4). 
 
Table 4: Prevalence of Hepatitis B Markers among Blood Donors 
Based on Occupation 
 
 
There was high significant correlation amongst HBsAg and 
HBcAb at r=0.725 and p=0.0001. Also between HBsAg and 
HBeAb at r=0.820 and p=0.0001. Additionally, there was high 
significant correlation between HBcAb and HBsAb at r=0.278 and 
p=0.0001, as well as between HBcAb and HBeAb at r=0.725 and 
p=0.0001 while HBsAg and HBcAb have no significant correlation 






Table 5: Pearson Correlation Matrix of the Hepatitis B Virus 
(HBV) Markers 
 
**Correlation is significant at the p<0.01 
 
DISCUSSION 
In this study, 7.3 % prevalence of HBsAg detected in 165 blood 
samples analyzed is an indication of the occurrence of HBV 
among blood donors from NBTS centre in Kaduna, Nigeria. This 
moreover indicates that HBV infection is endemic in the region of 
the study, and this might be ascribed to not receiving the 
complete doses of the vaccine and also due to individual behavior 
and practices in the studied area. The prevalence of HBsAg 
reported in this study is lower than 4.87 % as stated in a previous 
study which was 12 % as reported by Edia-Asuke et al. (2016).  
Also the prevalence of 7.3 % stated in this study is lower than 0.4 
% as reported in a previous study which was 7.7 % as carried out 
by Ikerionwu (2018).  
According to gender differences, it has shown that female blood 
donors had higher seropositivity for the HBV markers than the 
male counterpart, although the difference was not statistically 
significant (p>0.05). The number of males higher than female is 
due to the fact that male donate more blood than the females, 
issue like menstrual cycle and child birth are some of the reasons 
why females donate lesser that males. The cause for this 
difference may be because of the high number of male blood 
donors enrolled for this study than females. The result in this 
study correspond to Edia-Asuke et al. (2016), who stated that 
females are more infected with HBsAg than the male counterpart. 
Other reason for the high infection rate among females might be 
due to multiple sexual partnership, having unprotected sex and 
other unhygienic activities engaged by the youth (Lawal, 2009; 
Augustine et al., 2014; Innocent et al., 2015). This result showed 
no significant differences (p<0.05) in relation to the HBV markers 
which is similar to Innocent et al. (2015). However, this study 
contradicts the previous findings by Ndako et al. (2016), which 
reported higher prevalence for HBsAg in male than in females. 
This is quite high in view of the fact that the study subjects seem 
to be healthy population. Similar result was recorded in Lagos, 
Nigeria by Balogun (2010). A related survey also stated higher 
hepatitis B surface antigen prevalence in males than females 
among patients attending dental Clinic in University College 
Hospital, Ibadan, Nigeria, this might be due shorter carrier rate of 
HBsAg in females compared to males as reported by Lawal 
(2009). 
The highest prevalence of Hepatitis B markers is detected among 
the blood of donors between the age group of 18-27 years old. 
This high prevalence rate in younger people may be related to 
their active sexual activities and drug abuse, similar to the result 
32 
Science World Journal Vol. 15(No 2) 2020 
www.scienceworldjournal.org 
ISSN 1597-6343 
Published by Faculty of Science, Kaduna State University 
 
Sero-Prevalence of Hepatitis B Markers Among Blood Donors from National Blood 
Transfusion Service Centre in Kaduna, Nigeria 
 
reported by Buseri et al., (2009). This study contradicts the earlier 
report with high prevalence of HBV in older subjects 40 years and 
above than in younger people Lawal (2009), Okonko (2011) and 
Innocent et al. (2015). All age groups showed highly significant 
association with HBsAb (χ2 = 13.373, df= 4, p= 0.010). HBsAb 
presence can be due to the fact that it develops in individuals who 
have been vaccinated for Hepatitis b infection, so this can be the 
reason why these individuals are positive for HBsAb. 
In regard to occupation, blood donors who are self-employed 
have significantly higher positivity for HBV markers as compared 
with other line of works. This study contradicts what had been 
previously reported by Augustine et al. (2014), which stated that 
students have low prevalence of HBsAg whereas in this study 
students have high positivity for HBsAg. All line of work showed 
highly significant association with HBcAb (χ2 = 10.860, df= 4, p= 
0.028). HBcAb indicates a previous or ongoing infection and this 
might be due to exposure, the kind of work people get involve into 
can lead to hepatitis B infection. 
There was high significant correlation amongst HBsAg and 
HBcAb at r=0.725 and p=0.0001. Also between HBsAg and 
HBeAb at r=0.820 and p=0.0001. Additionally, there was high 
significant correlation between HBcAb and HBsAb at r=0.278 and 
p=0.0001, as well as between HBcAb and HBeAb at r=0.725 and 
p=0.0001 while HBsAg and HBcAb have no significant correlation 
with any other Hepatitis B virus (HBV) markers. This work 
contradicts the work of Innocent et al. (2015), who reported a 
strong correlation between HBsAg and HBeAg. 
 
Conclusion 
The study revealed an overall low prevalence of Hepatitis B 
markers among healthy blood donors from National Blood 
Transfusion Service Centre in Kaduna. Female blood donors had 
higher seropositivity for the HBV markers than the male 
counterpart but the differences were not significant. The highest 
prevalence of HBV markers was detected among the younger 
blood donors. Self-employed blood donors showed higher 
positivity for HBV markers compared to other line of works. Blood 
transfusion, sexual contact during window period or late phase 
chronic HBV infection are significant predictors of HBV infection 
among the study groups The presence of Hepatitis B virus in the 
blood of donors could pose some health risks on the blood 
recipients. There is need for inclusion of Hepatitis B profile test 
and the introduction of Polymerase chain reaction (PCR) in 
routine screening of blood donors in Nigeria in order to minimize 
the risk of transfusing blood with HBV infection. 
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